openPR Logo
Press release

Over the Counter (OTC) Drugs & Dietary Supplements Sales Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017

10-24-2017 01:24 PM CET | Health & Medicine

Press release from: Over the Counter (OTC) Drugs & Dietary Supplements

Market Research Report

Market Research Report

Researchmoz added Most up-to-date research on "Over the Counter (OTC) Drugs & Dietary Supplements Sales Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017" to its huge collection of research reports.

In this report, the global Over the Counter (OTC) Drugs & Dietary Supplements market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Over the Counter (OTC) Drugs & Dietary Supplements for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Over the Counter (OTC) Drugs & Dietary Supplements market competition by top manufacturers/players, with Over the Counter (OTC) Drugs & Dietary Supplements sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Novartis International
Roche Holding
Merck
Sanofi
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline
Bayer Healthcare
AstraZeneca
Alacer
Alcon
Alfresa Pharma Corporation
Alkalon
Alliance Healthcare
Allergan
Reckitt Benckiser
Bausch & Lomb

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Branded Drugs
Generic Drugs

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1336596

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Over the Counter (OTC) Drugs & Dietary Supplements for each application, including
Pharmacies
Grocery Stores
Vitamin and Health Food Stores
Online Pharmacy
Others

Table of Contents

Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Report 2017
1 Over the Counter (OTC) Drugs & Dietary Supplements Market Overview
1.1 Product Overview and Scope of Over the Counter (OTC) Drugs & Dietary Supplements
1.2 Classification of Over the Counter (OTC) Drugs & Dietary Supplements by Product Category
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Branded Drugs
1.2.4 Generic Drugs

2 Global Over the Counter (OTC) Drugs & Dietary Supplements Competition by Players/Suppliers, Type and Application
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Competition by Players/Suppliers
2.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements (Volume and Value) by Type
2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales and Market Share by Type (2012-2017)

Browse More Details @ https://www.researchmoz.us/global-over-the-counter-otc-drugs-and-dietary-supplements-sales-market-report-2017-report.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Over the Counter (OTC) Drugs & Dietary Supplements Sales Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 here

News-ID: 783384 • Views:

More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current